Healthcare

BioNxt Announces Shares for Debt Settlement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS…

3 months ago

Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care

VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")is pleased to…

3 months ago

Myriad Systems Launches Myriad Motion to Revolutionize EHR Onboarding

System empowers providers to launch a fully integrated practice management solution, enhancing efficiency and patient careWHITE PLAINS, N.Y.--(BUSINESS WIRE)--#AIinHealthcare--Myriad Systems,…

3 months ago

MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation

SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% weight loss and…

4 months ago

Zomedica’s Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope – Transforming Veterinary Imaging

Cutting-Edge Digital Microscopy System Featured in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire /…

4 months ago

HealthLynked Strengthens Intellectual Property Portfolio with New Patent Filings in AI and Patient Record Management

NAPLES, Fla., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in patient-centric healthcare…

4 months ago

Anosh Inc Foundation, Led by Anosh Ahmed, Aims to Deliver 100,000 Free Meals in Dubai and Pakistan

Building on its Ramadan campaign, the foundation expands food relief efforts to reach vulnerable communities year-round. Philanthropist Anosh Ahmed with…

4 months ago

ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer

Dr. Barbara Klencke is an accomplished clinical leader with a distinguished track record in oncology drug development who currently serves…

4 months ago

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End

1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1…

4 months ago

Interim results for the six months ended June 30, 2025

September 12, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2025 Biodexa…

4 months ago